Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Current Hematologic Malignancy Reports|March 17, 2012
Clinical trials in chronic myeloid leukemiaSusanne Saussele, Markus PfirrmannLeukemia|April 15, 2025
Prognostic scoring systems in chronic myeloid leukaemiaMichael Lauseker, Verena S Hoffmann, Markus PfirrmannBlood|March 14, 2014
The impact of health care settings on survival time of patients with chronic myeloid leukemiaMichael Lauseker, Joerg Hasford, Markus Pfirrmann, et al.Annals of Hematology|March 28, 2015
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of deathMarkus Pfirrmann, Michael Lauseker, Verena S Hoffmann, et al.Annals of Hematology|December 4, 2014
A multi-state model approach for prediction in chronic myeloid leukaemiaMichael Lauseker, Joerg Hasford, Verena S Hoffmann, et al.Leukemia|January 25, 2019
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overviewMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.The Lancet. Oncology|December 27, 2011
Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trialMarkus Pfirrmann, Gerhard Ehninger, Christian Thiede, et al.Cancer|February 14, 2017
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature deathMichael Lauseker, Joerg Hasford, Susanne Saussele, et al.Leukemia & Lymphoma|December 7, 2021
<i>SOCS-2</i> gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatmentDamla Buket Egeli, Benjamin Hanfstein, Michael Lauseker, et al.Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.Pageof 6